Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 11:08 PM
Study NCT ID:
NCT00520767
Status:
COMPLETED
Last Update Posted:
2023-12-22
First Post:
2007-08-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2006-132
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |